HETERO LABS LIMITED

Location

Telangana

Founded

1989-03-10

Website

https://www.hetero.com

Risk Signals

263 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Product Recall (66) Acquisition Announcements (48) New Product Release (47) Public Health Crisis Response (46) Quality Assurance & Safety (24) Legal Proceedings (22) Business Growth Initiatives (17) Inter-Organizational Collaborations (15) Asset Divestment (15) Corporate Deals (14) Cybersecurity Breaches (14) Investment Strategies (13) Corporate Rebranding (12) Competitive Market Dynamics (12) Market Entry (11) Employee Safety & Health (10) Environmental Assessments (8) Litigation Settlements (8) Ongoing Legal Investigations (8) Sustainable Practices (7) Executive Leadership Changes (7) Regulatory Updates (6) Workplace Safety incidents (5) Access and Affordability Initiatives (5) Workforce Reductions (5) Materials Sourcing and Efficiency (5) Water Management (4) Renewable Energy Innovations (4) Explosion and Gas Leak Incidents (4) Government Affairs (3)

Recent Articles about HETERO LABS LIMITED

Live alerts from global media, monitored by Business Radar

FDA Approves Generic Nilotinib: Expanding Access to Chronic Myeloid Leukemia Treatment -

2024-12-24 (oncodaily.com)

FDA Approves Generic Nilotinib: Expanding Access to Chronic Myeloid Leukemia Treatment -

FDA Approves Generic Nilotinib: Expanding Access to Chronic Myeloid Leukemia Treatment / Access to Oncology Medicines Coalition, cancer, chronic myeloid

Read more
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries

2024-10-03 (prnewswire.co.uk)

Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries

/PRNewswire/ -- Hetero, India's leading pharmaceutical company with the widest global reach, today announced a new partnership with Gilead Sciences Ireland UC...

Read more
Searchlight: Hetero Health rebounds after post-COVID crash on manufacturing boost

2024-09-03 (vccircle.com)

Searchlight: Hetero Health rebounds after post-COVID crash on manufacturing boost

Hetero Healthcare Ltd, which is a part of one of the major pharmaceutical groups in India Hetero group, witnessed a ...

Read more

Never miss a headline about HETERO LABS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages